Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Tianjin, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-09-17 | NCT07585760 | |
| BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis | Systemic Light Chain Amyloidosis | Recruiting | Phase 2 | 2026-07-23 | NCT07151690 |